Higher dose antimalarial may be needed to combat relapsing malaria

Analysis of data from more than 6,800 patients located across 16 countries has supported the need to increase the dose of the antimalarial drug, primaquine, in malaria endemic countries.

Leave A Comment

Your email address will not be published. Required fields are marked *